Deuterium exchange and mass spectrometry reveal the interaction differences of two synthetic modulators of RXRα LBD
暂无分享,去创建一个
M. Deinzer | M. Leid | Efrén Pérez | A. D. de Lera | M. Schimerlik | Xuguang Yan | Michael I. Schimerlik | Max L. Deinzer
[1] W. Ellmeier,et al. Down-regulation of RXRalpha expression is essential for neutrophil development from granulocyte/monocyte progenitors. , 2007, Blood.
[2] M. Deinzer,et al. Investigation of ligand interactions with human RXRα by hydrogen/deuterium exchange and mass spectrometry , 2006, Journal of the American Society for Mass Spectrometry.
[3] A. Itai,et al. A new RXR agonist, HX630, suppresses intimal hyperplasia in a mouse blood flow cessation model. , 2006, Journal of molecular and cellular cardiology.
[4] I. Ho,et al. Cutting Edge: Inhibition of the Retinoid X Receptor (RXR) Blocks T Helper 2 Differentiation and Prevents Allergic Lung Inflammation , 2006, The Journal of Immunology.
[5] L. Altucci,et al. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor. , 2005, Cancer research.
[6] V. Vivat-Hannah,et al. Retinoids as therapeutic agents: today and tomorrow. , 2005, Mini reviews in medicinal chemistry.
[7] Paul Webb,et al. Conformational adaptation of nuclear receptor ligand binding domains to agonists: Potential for novel approaches to ligand design , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[8] K. Hede. Rexinoids may be ready for prime time in prevention, but challenges remain. , 2004, Journal of the National Cancer Institute.
[9] A. Szántó,et al. Retinoid X receptors: X-ploring their (patho)physiological functions , 2004, Cell Death and Differentiation.
[10] H. Xu,et al. Structure-based design of potent retinoid X receptor alpha agonists. , 2004, Journal of medicinal chemistry.
[11] F. Villarroya,et al. Retinoids and retinoid receptors in the control of energy balance: novel pharmacological strategies in obesity and diabetes. , 2004, Current medicinal chemistry.
[12] M. Deinzer,et al. Dynamics and ligand-induced solvent accessibility changes in human retinoid X receptor homodimer determined by hydrogen deuterium exchange and mass spectrometry. , 2004, Biochemistry.
[13] R. Evans,et al. The Structural Basis for the Specificity of Retinoid-X Receptor-selective Agonists: New Insights Into the Role of Helix H12* , 2002, The Journal of Biological Chemistry.
[14] Neil J. McKenna,et al. Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.
[15] Millard H. Lambert,et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα , 2002, Nature.
[16] Hai Pan,et al. Hydrogen Exchange-Mass Spectrometry , 2002, Molecular & Cellular Proteomics.
[17] S. Dakoji,et al. Studies on the inactivation of bovine liver enoyl-CoA hydratase by (methylenecyclopropyl)formyl-CoA: elucidation of the inactivation mechanism and identification of cysteine-114 as the entrapped nucleophile. , 2001, Journal of the American Chemical Society.
[18] F. Rastinejad. Retinoid X receptor and its partners in the nuclear receptor family. , 2001, Current opinion in structural biology.
[19] L. Hamann. An Efficient, Stereospecific Synthesis of the Dimer‐Selective Retinoid X Receptor Modulator (2E,4E,6Z)‐7‐ [5,6,7,8‐Tetrahydro‐5,5,8,8‐tetramethyl‐2‐(n‐propyloxy)naphthalen‐3‐yl] ‐3‐methylocta‐2,4,6‐trienoic Acid. , 2000 .
[20] L. Hamann. An efficient, stereospecific synthesis of the dimer-selective retinoid X receptor modulator (2E,4E,6Z)-7-[5,6,7,8- tetrahydro-5,5, 8,8-tetramethyl-2-(n-propyloxy)naphthalen-3-yl]-3-methyl octa-2,4, 6-trienoic acid. , 2000, The Journal of organic chemistry.
[21] L. Freedman. Increasing the Complexity of Coactivation in Nuclear Receptor Signaling , 1999, Cell.
[22] Jaime Prilusky,et al. Automated analysis of interatomic contacts in proteins , 1999, Bioinform..
[23] L. Hamann,et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists , 1997, Nature.
[24] L. Dardashti,et al. Identification of the first retinoid X, receptor homodimer antagonist. , 1996, Journal of medicinal chemistry.
[25] R. Evans,et al. The RXR heterodimers and orphan receptors , 1995, Cell.
[26] J M Thornton,et al. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.
[27] J. Thornton,et al. Satisfying hydrogen bonding potential in proteins. , 1994, Journal of molecular biology.
[28] G. Vriend,et al. The use of in vitro peptide binding profiles and in silico ligand-receptor interaction profiles to describe ligand-induced conformations of the retinoid X receptor alpha ligand-binding domain. , 2007, Molecular endocrinology.
[29] L Nagy,et al. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death. , 2003, Journal of biological regulators and homeostatic agents.
[30] D. D. Perrin,et al. Purification of Laboratory Chemicals , 2022 .